Bayer Aktiengesellschaft BAYN.F Stock
Bayer Aktiengesellschaft Price Chart
Bayer Aktiengesellschaft BAYN.F Financial and Trading Overview
Bayer Aktiengesellschaft stock price | 27.54 EUR |
Previous Close | 26.29 EUR |
Open | 26.37 EUR |
Bid | 26 EUR x 120000 |
Ask | 26.55 EUR x 120000 |
Day's Range | 25.96 - 26.7 EUR |
52 Week Range | 24.98 - 61.9 EUR |
Volume | 20.5K EUR |
Avg. Volume | 24.44K EUR |
Market Cap | 25.81B EUR |
Beta (5Y Monthly) | 0.974 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.17 EUR |
Forward Dividend & Yield | 0.11 (0.41%) |
Ex-Dividend Date | April 29, 2024 |
1y Target Est | N/A |
BAYN.F Valuation Measures
Enterprise Value | 60.35B EUR |
Trailing P/E | N/A |
Forward P/E | 3.749286 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.54187274 |
Price/Book (mrq) | 0.7830589 |
Enterprise Value/Revenue | 1.267 |
Enterprise Value/EBITDA | 5.326 |
Trading Information
Bayer Aktiengesellschaft Stock Price History
Beta (5Y Monthly) | 0.974 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 61.9 EUR |
52 Week Low | 24.98 EUR |
50-Day Moving Average | 30.53 EUR |
200-Day Moving Average | 41.36 EUR |
BAYN.F Share Statistics
Avg. Volume (3 month) | 24.44K EUR |
Avg. Daily Volume (10-Days) | 23.16K EUR |
Shares Outstanding | 982.42M |
Float | 982.32M |
Short Ratio | N/A |
% Held by Insiders | 0.025% |
% Held by Institutions | 49.15% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.11 |
Trailing Annual Dividend Yield | 0.41% |
5 Year Average Dividend Yield | 462.00% |
Payout Ratio | 1.6327001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2023 |
Most Recent Quarter (mrq) | December 31, 2023 |
Next Fiscal Year End | December 31, 2024 |
Profitability
Profit Margin | -6.17% |
Operating Margin (ttm) | 79.04% |
Gross Margin | 58.54% |
EBITDA Margin | 23.78% |
Management Effectiveness
Return on Assets (ttm) | 4.04% |
Return on Equity (ttm) | -8.17% |
Income Statement
Revenue (ttm) | 47.64B EUR |
Revenue Per Share (ttm) | 48.49 EUR |
Quarterly Revenue Growth (yoy) | -1.19% |
Gross Profit (ttm) | N/A |
EBITDA | 11.33B EUR |
Net Income Avi to Common (ttm) | -2940999936 EUR |
Diluted EPS (ttm) | -2.99 |
Quarterly Earnings Growth (yoy) | 118.79% |
Balance Sheet
Total Cash (mrq) | 10.59B EUR |
Total Cash Per Share (mrq) | 10.78 EUR |
Total Debt (mrq) | 45.01B EUR |
Total Debt/Equity (mrq) | 136.06 EUR |
Current Ratio (mrq) | 1.275 |
Book Value Per Share (mrq) | 33.516 |
Cash Flow Statement
Operating Cash Flow (ttm) | 5.12B EUR |
Levered Free Cash Flow (ttm) | 1.52B EUR |
Profile of Bayer Aktiengesellschaft
Country | Germany |
State | N/A |
City | Leverkusen |
Address | Kaiser-Wilhelm-Allee 1 |
ZIP | 51368 |
Phone | 49 214 30 1 |
Website | https://www.bayer.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 96931 |
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Q&A For Bayer Aktiengesellschaft Stock
What is a current BAYN.F stock price?
Bayer Aktiengesellschaft BAYN.F stock price today per share is 27.54 EUR.
How to purchase Bayer Aktiengesellschaft stock?
You can buy BAYN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bayer Aktiengesellschaft?
The stock symbol or ticker of Bayer Aktiengesellschaft is BAYN.F.
Which industry does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft industry is Drug Manufacturers-General.
How many shares does Bayer Aktiengesellschaft have in circulation?
The max supply of Bayer Aktiengesellschaft shares is 983.86M.
What is Bayer Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?
Bayer Aktiengesellschaft PE Ratio is now.
What was Bayer Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?
Bayer Aktiengesellschaft EPS is -3.17 EUR over the trailing 12 months.
Which sector does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft sector is Healthcare.